Indoco Remedies

40
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
242.00
-21.3 (-8.09%)
BSENSE

Sep 15, 04:01 PM

BSE+NSE Vol: 3.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Indoco Remedies Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-103.00
-75.00
124.00
192.00
236.00
132.00
Adjustment
249.00
183.00
137.00
120.00
87.00
109.00
Changes In working Capital
54.00
2.00
-87.00
-73.00
-108.00
-139.00
Cash Flow after changes in Working Capital
201.00
111.00
174.00
240.00
214.00
101.00
Cash Flow from Operating Activities
192.00
94.00
156.00
178.00
173.00
82.00
Cash Flow from Investing Activities
-101.00
-339.00
-433.00
-208.00
-121.00
-66.00
Cash Flow from Financing Activities
-76.00
241.00
280.00
22.00
-44.00
-29.00
Net Cash Inflow / Outflow
13.00
-2.00
3.00
-6.00
8.00
-14.00
Opening Cash & Cash Equivalents
12.00
14.00
10.00
17.00
9.00
23.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
25.00
12.00
14.00
10.00
17.00
9.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Indoco Remedies
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-8.59
13.34
-21.00
-164.39%
Adjustment
178.18
2.12
176.00
8304.72%
Changes In working Capital
65.55
-3.78
68.00
1834.13%
Cash Flow after changes in Working Capital
235.14
11.68
224.00
1913.18%
Cash Flow from Operating Activities
226.35
7.92
219.00
2757.95%
Cash Flow from Investing Activities
-87.38
-1.26
-86.00
-6834.92%
Cash Flow from Financing Activities
-133.09
-4.52
-129.00
-2844.47%
Net Cash Inflow / Outflow
5.87
2.14
3.00
174.30%
Opening Cash & Cash Equivalents
7.06
9.98
-2.00
-29.26%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
12.94
12.12
0.00
6.77%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 102.48% vs -39.41% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
192.23
94.94
102.48%